INNOVATIVE DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
Biopharmaceutical / Biotechnology Innovator
We are a disruptive emerging biopharmaceutical/biotechnology innovator, challenging the status quo by shifting traditional medical paradigms. Our purpose is to push the boundaries to drive innovation by turning groundbreaking science into cutting-edge diagnostics and therapeutics.
Our BioSync™ Platform
The BioSync™ Platform is the first and only platform that integrates Agribiopharmaceuticals with Biopharmaceuticals and Biotechnology.
This advanced data procurement creates the most robust and innovative data management platform in the world.
IN THE NEWS:
Vyripharm International, Inc. and the National Yang-Ming University Signed a MOU to Develop VYR-206 as a Novel Diagnostic Approach for Neurological Disorders Outcomes Following Treatments.
Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19.
Vyripharm Biopharmaceuticals Is in the Development Stage of a Novel Integrated Theranostic Approach for the Treatment of Viral Infections Such as COVID-19.
We are a global biopharmaceutical and biotechnology leader integrating traditional and alternative medicine.
We design innovative diagnostic and therapeutic applications. Our technologies advance personalized care and precision medicine utilizing data analytics and artificial intelligence.
Helping people live better lives by providing
Standardization for Public Health and Public Safety.
The integration of traditional medicine with alternative medicine.
Increased Oversight of the Cannabinoid Industry Reduces the
Risk to Public Health and Safety.
– Eddie Patton Jr., M.D.
CMO Vyripharm Enterprises